MariMed Inc.
MRMD
Rank in Stocks
#24864
MariMed Inc. is a key player in the cannabis industry, involved in the... MariMed Inc. is a key player in the cannabis industry, involved in the cultivation, production, and distribution of both medicinal and adult-use cannabis products across the United States and internationally. The company's diverse brand portfolio includes Nature's Heritage for cannabis genetics, flowers, and concentrates, while Kalm Fusion offers cannabis-infused chewable tablets and powdered drink mixes. Its edibles segment features natural fruit chews under the Betty's Eddies brand and a variety of baked goods like brownies and cookies from Bubby's Baked. Additionally, MariMed develops cannabidiol (CBD) formulations under the Florance brand. The company further expands its operations by licensing its proprietary brands and product formulations, and by leasing cannabis-specific facilities. MariMed Inc. was founded in 2011 and maintains its headquarters in Norwood, Massachusetts.
Share Price
$0.0752
Last synced: 2026-11-09
Market Cap
$30.02M
Change (1 day)
12.24%
Change (1 year)
-24.35%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade MariMed Inc. (MRMD)
Category
Healthcare
Operating Margin for MariMed Inc. (MRMD)
Operating Margin as of November 2026 TTM: -0.93%
According to MariMed Inc.'s latest financial reports, its current operating margin (TTM) is -0.93%. At the end of 2025 the company had an operating margin of -1.29%.
Operating Margin history for MariMed Inc. from 2011 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -0.93% | -27.91% |
| 2025 | -1.29% | -170.11% |
| 2024 | 1.84% | -81.87% |
| 2023 | 10.15% | -33.22% |
| 2022 | 15.20% | -31.28% |
| 2021 | 22.12% | -22.52% |
| 2020 | 28.55% | 132.30% |
| 2019 | 12.29% | -127.20% |
| 2018 | -45.19% | -327.43% |
| 2017 | 19.87% | 15.79% |
| 2016 | 17.16% | -112.89% |
| 2015 | -133.10% | -85.61% |
| 2014 | -924.77% | -98.50% |
| 2013 | -61,741.70% | -37.44% |
| 2012 | -98,698.98% | 33,078.36% |
| 2011 | -297.48% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -120.87% |
DE
|
|
| 19.68% | -121.16% |
DE
|
|
| 13.26% | -114.26% |
JP
|
|
| 17.08% | -118.37% |
CH
|
|
| 14.92% | -116.04% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about MariMed Inc.'s operating margin
What is MariMed Inc.'s operating margin?
MariMed Inc.'s operating margin is -0.93%, as of Nov 2026.
What was MariMed Inc.'s operating margin in 2025?
In 2025, MariMed Inc.'s operating margin was -1.29%, compared with 1.84% in 2024.
How has MariMed Inc.'s operating margin changed since 2020?
From 2020 to 2025, MariMed Inc.'s operating margin was highest in 2020 (28.55%) and lowest in 2025 (-1.29%).
How does MariMed Inc.'s operating margin compare with similar companies?
MariMed Inc.'s operating margin (-0.93%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.